NLS PHARMACEUTICS LTD
CUSIP H57830111
Nls Pharmaceutics Ltd has 6 institutional holders in Filings Flow’s 13F database, together reporting 973.8K shares worth $261,145 as of Q4 2022. The largest reported holders are Wolverine Asset Management LLC, Clear Street LLC, and Clear Street Group Inc..
Institutional Holders
6
Q4 2022
Reported Value
$261,145
Ticker
unmapped
private placement or foreign
Quarters Tracked
3
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC$10.4B AUM | 0.00% | $3,185 | 245.0K | Q4 2024OLDER |
| CLEAR STREET LLC$25.1B AUM | 0.00% | $1,155 | 57.8K | Q2 2025OLDER |
| ARMISTICE CAPITAL, LLC$5.6B AUM | 0.00% | $250 | 12.5K | Q2 2025OLDER |
| Clear Street Group Inc.$24.6B AUM | 0.00% | $1,028 | 57.8K | Q3 2025 |
| Hudson Bay Capital Management LP$29.0B AUM | 0.00% | $821 | 71.4K | Q4 2024OLDER |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP$893.3B AUM | 0.00% | $731 | 45.8K | Q3 2025 |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $237 | 18.4K | Q1 2025OLDER |
| UBS Group AG$666.3B AUM | 0.00% | $8 | 424 | Q3 2025 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.